Distinct phosphatases antagonize the p53 response in different phases of the cell cycle

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 20, 2014, Pages 7313-7318

  Shaltiel, Indra A ^a   Aprelia, Melinda ^a   Saurin, Adrian T ^b   Chowdhury, Dipanjan ^c   Kops, Geert J P L ^d,e   Voest, Emile E ^d,f   Medema, René H ^a,d  

^a Division of Molecular Biology   (Netherlands)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Cancer Genomics Center   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 4; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; DNA DAMAGE; G1 PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROTEIN ANALYSIS; TRANSCRIPTION INITIATION;

CELL CYCLE; CHECKPOINT KINASE 2; CYCLIN B1; DNA; DNA DAMAGE; FIBROBLASTS; G1 PHASE; G2 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUMINESCENT PROTEINS; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RETINAL PIGMENT EPITHELIUM; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901044583     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1322021111     Document Type: Article

References (43)

1. Harper JW, Elledge SJ (2007) The DNA damage response: Ten years after. Mol Cell 28(5):739-745.
2. Ciccia A, Elledge SJ (2010) The DNA damage response: Making it safe to play with knives. Mol Cell 40(2):179-204.
3. Matsuoka S, Huang M, Elledge SJ (1998) Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282(5395):1893-1897.
4. Liu Q, et al. (2000) Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev 14(12):1448-1459.
5. Reinhardt HC, Aslanian AS, Lees JA, Yaffe MB (2007) p53-deficient cells rely on ATMand ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 11(2):175-189.
6. Raman M, Earnest S, Zhang K, Zhao Y, Cobb MH (2007) TAO kinases mediate activation of p38 in response to DNA damage. EMBO J 26(8):2005-2014.
7. Reinhardt HC, Yaffe MB (2009) Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. Curr Opin Cell Biol 21(2):245-255.
8. Katayose D, Wersto R, Cowan KH, Seth P (1995) Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis. Cell Growth Differ 6(10):1207-1212.
9. Agarwal ML, Agarwal A, Taylor WR, Stark GR (1995) p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA 92(18):8493-8497.
10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82(4): 675-684.
11. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB (1992) Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA 89(16): 7491-7495.
12. Lindqvist A, et al. (2009) Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J 28(20):3196-3206.
13. Fiscella M, et al. (1997) Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 94(12):6048-6053.
14. Takekawa M, et al. (2000) p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 19(23):6517-6526.
15. Lu X, Nannenga B, Donehower LA (2005) PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev 19(10):1162-1174.
16. Lu X, et al. (2007) The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell 12(4):342-354.
17. Shreeram S, et al. (2006) Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell 23(5):757-764.
18. Macurek L, et al. (2010) Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene 29(15): 2281-2291.
19. Fujimoto H, et al. (2006) Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ 13(7):1170-1180.
20. Sakaue-Sawano A, et al. (2008) Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132(3):487-498.
21. Gingras AC, et al. (2005) A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol Cell Proteomics 4(11):1725-1740.
22. Sousa-Nunes R, Chia W, Somers WG (2009) Protein phosphatase 4 mediates localization of the Miranda complex during Drosophila neuroblast asymmetric divisions. Genes Dev 23(3):359-372.
23. Han X, et al. (2009) The role of protein phosphatase 4 in regulating microtubule severing in the Caenorhabditis elegans embryo. Genetics 181(3):933-943.
24. Oler AJ, Cairns BR (2012) PP4 dephosphorylates Maf1 to couple multiple stress conditions to RNA polymerase III repression. EMBO J 31(6):1440-1452.
25. Lyu J, Jho EH, Lu W (2011) Smek promotes histone deacetylation to suppress transcription of Wnt target gene brachyury in pluripotent embryonic stem cells. Cell Res 21(6):911-921.
26. Lee DH, et al. (2010) A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination. Nat Struct Mol Biol 17(3):365-372.
27. Chowdhury D, et al. (2008) A PP4-phosphatase complex dephosphorylates gamma- H2AX generated during DNA replication. Mol Cell 31(1):33-46.
28. Falk JE, Chan AC, Hoffmann E, Hochwagen A (2010) A Mec1- and PP4-dependent checkpoint couples centromere pairing to meiotic recombination. Dev Cell 19(4): 599-611.
29. Nakada S, Chen GI, Gingras AC, Durocher D (2008) PP4 is a gamma H2AX phosphatase required for recovery from the DNA damage checkpoint. EMBO Rep 9(10):1019-1026.
30. Gomes NP, Espinosa JM (2010) Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes. Cell Cycle 9(17): 3428-3437.
31. Li X, et al. (2007) Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. J Biol Chem 282(50):36177-36189.
32. Lee YK, Thomas SN, Yang AJ, Ann DK (2007) Doxorubicin down-regulates Kruppelassociated box domain-Associated protein 1 sumoylation that relieves its transcription repression on p21WAF1/CIP1 in breast cancer MCF-7 cells. J Biol Chem 282(3): 1595-1606.
33. Hu C, et al. (2012) Roles of Kruppel-Associated Box (KRAB)-Associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response. J Biol Chem 287(23): 18937-18952.
34. White D, et al. (2012) The ATM substrate KAP1 controls DNA repair in heterochromatin: Regulation by HP1 proteins and serine 473/824 phosphorylation. Mol Cancer Res 10(3):401-414.
35. Chang CW, et al. (2008) Phosphorylation at Ser473 regulates heterochromatin protein 1 binding and corepressor function of TIF1beta/KAP1. BMC Mol Biol 9:61.
36. Lee DH, et al. (2012) Phosphoproteomic analysis reveals that PP4 dephosphorylates KAP-1 impacting the DNA damage response. EMBO J 31(10):2403-2415.
37. Lukas J, et al. (1994) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cells requirement for cyclin D1 function in G1. J Cell Biol 125(3):625-638.
38. Crawford LV, Pim DC, Gurney EG, Goodfellow P, Taylor-Papadimitriou J (1981) Detection of a common feature in several human tumor cell lines-A 53,000-dalton protein. Proc Natl Acad Sci USA 78(1):41-45.
39. Choi J, et al. (2002) Mice deficient for the wild-type p53-induced phosphatase gene (Wip1) exhibit defects in reproductive organs, immune function, and cell cycle control. Mol Cell Biol 22(4):1094-1105.
40. Harrison M, Li J, Degenhardt Y, Hoey T, Powers S (2004) Wip1-deficient mice are resistant to common cancer genes. Trends Mol Med 10(8):359-361.
41. Wang B, et al. (2008) Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell Res 18(9):974-977.
42. Weng S, et al. (2012) Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 21(8):1336-1343.
43. Rauta J, et al. (2006) The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res Treat 95(3):257-263.